Related Experiment Video
Updated: May 18, 2026
09:07
Analyzing the Functions of Mast Cells In Vivo Using 'Mast Cell Knock-in' Mice
Published on: May 27, 2015
Mast Cell Leukaemia: c-KIT Mutations Are Not Always Positive
Magalie Joris1, Sophie Georgin-Lavialle, Marie-Olivia Chandesris
1Service d'Hématologie, Centre Hospitalier Universitaire, Avenue Laennec, 80054 Amiens, France.
Case Reports in Hematology
|September 22, 2012
Summary
Mast cell leukemia (MCL) is a rare, aggressive cancer. Identifying the D816V c-KIT mutation is key for diagnosis and treatment planning in mast cell leukemia.
Area of Science:
- Hematology
- Oncology
- Molecular Biology
Background:
- Mast cell leukemia (MCL) is a rare and aggressive hematologic malignancy.
- It is characterized by a poor prognosis and limited survival.
- The D816V c-KIT mutation is a frequent molecular driver in MCL pathogenesis.
Purpose of the Study:
- To describe a case of mast cell leukemia with unusual characteristics.
- To review current diagnostic and therapeutic strategies for MCL.
- To highlight the importance of molecular investigations in guiding treatment.
Main Methods:
- Case report of a patient with rare phenotypic and genotypic MCL features.
- Review of existing literature on clinical, biological, and therapeutic approaches in MCL.
- Molecular analysis to identify key mutations, including D816V c-KIT.
Main Results:
- Detailed description of a unique MCL patient case.
- Confirmation of the D816V c-KIT mutation's role in disease development.
- Discussion of treatment implications based on patient's specific characteristics.
Conclusions:
- Comprehensive diagnostic and molecular investigations are crucial for MCL.
- Tailoring therapeutic choices based on individual patient profiles, including mutations, is essential.
- Further research into rare MCL presentations and treatment optimization is warranted.
